Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice
Authors
Keywords
-
Journal
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume 16, Issue 5, Pages 546-558
Publisher
SAGE Publications
Online
2016-07-12
DOI
10.1177/1533034616657976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Cancer Natural Products Inducing Cross-talk between Apoptosis and Autophagy Mutual Proteins to Regulate Cancer Cell Death: Design of Future Green Anticancer Therapies
- (2015) Soundararajan Vijayarathna et al. Asian Pacific Journal of Cancer Prevention
- Mitochondrial apoptosis: killing cancer using the enemy within
- (2015) J Lopez et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
- (2015) Lina Yang et al. CANCER LETTERS
- Epibrassinolide alters PI3K/MAPK signaling axis via activating Foxo3a-induced mitochondria-mediated apoptosis in colon cancer cells
- (2015) Deniz Coskun et al. EXPERIMENTAL CELL RESEARCH
- Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG
- (2015) María Isabel Cerezo-Guisado et al. FOOD AND CHEMICAL TOXICOLOGY
- Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model
- (2015) Subhayan Sur et al. MOLECULAR CARCINOGENESIS
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Targeting extrinsic apoptosis in cancer: Challenges and opportunities
- (2015) Simone Fulda SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells
- (2015) Jen-Pi Tsai et al. Oncotarget
- P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma
- (2014) Takeshi Terashima et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- c-Myc Quadruplex-forming Sequence Pu-27 Induces Extensive Damage in Both Telomeric and Nontelomeric Regions of DNA
- (2014) Md Ashraful Islam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
- (2012) S. X. Ren et al. CANCER RESEARCH
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Prevention of liver carcinogenesis by amarogentin through modulation of G 1 /S cell cycle check point and induction of apoptosis
- (2012) Debolina Pal et al. CARCINOGENESIS
- Regulation of the human catalytic subunit of telomerase (hTERT)
- (2012) Michael Daniel et al. GENE
- Tumor Suppressors p53, p63TAα, p63TAy, p73α, and p73β Use Distinct Pathways to Repress Telomerase Expression
- (2012) Yuan Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Telomerase and the search for the end of cancer
- (2012) Simone Mocellin et al. TRENDS IN MOLECULAR MEDICINE
- p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis
- (2009) Joana D. Amaral et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started